CXCR4 Theranostics: A Potential Game Changer in Solid Tumors and Hematological Malignancies

  • Baljinder S
  • Ankit W
  • Shekhawat A
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This open access book is written by world-renowned experts on radiomolecular precision oncology to celebrate the work, life, principles and ideology of Richard P Baum. It includes commentaries, reviews and some thought provoking novel ideas on radionuclide precision oncology, covering topics such as various aspects of theranostics and molecular radiotherapy like radiolabeled peptides, radiolabeled antibodies, dosimetry, and quality control as well as the diagnosis and treatment of specific tumor types. Featuring contributions by biologists, physicists, chemists, mathematicians, geneticists, and physicians from a range of specialties, this Festschrift is highly interdisciplinary and will be a valuable resource for future precision oncologists. ;

Cite

CITATION STYLE

APA

Baljinder, S., Ankit, W., Shekhawat, A. S., Ashwin, S., Malhotra, P., Waheed, A., … Behera, D. (2024). CXCR4 Theranostics: A Potential Game Changer in Solid Tumors and Hematological Malignancies. In Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum (pp. 309–320). Springer International Publishing. https://doi.org/10.1007/978-3-031-33533-4_31

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free